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Flubendazole is widely used anthelmintic drug belonging to benzimidazole group. The 
molecular mechanism of action of flubendazole is baed on specific binding to tubulin, which 
results in disruption of microtubule structure and function and in the interference with the 
microtubule-mediated transport of secretory vesicle in absorptive tissues of helminths. The 
microtubule-disrupting properties of benzimidazole derivatives raised recently interest in these 
compounds as possible anti-cancer agents. Because of available studies and pharmacological 
statements, it is supposed considerable concentrations of flubendazole in intestinal cells after 
p.o. administration could be reached, we performed this study to investigate the antiproliferative 
potential of flubendazole in a panel of intestinal c ncer cell lines. 
The colorectal carcinoma cell lines SW480, SW620 and o e cell line NCM460 isolated from 
normal colon mucosa were treated with different concentrations of flubendazole (0.1 – 10 µM) 
for 24, 48 and 72 hours. Cell viability was assayed using NRU test and WST-1 test. The effect 
of flubendazole on the cell cycle distribution of SW480 was analysed with flow cytometry. 
Other specific methods such as fluorescent staining of tubulin and nuclei, measurement of 
caspase 3 activity and β-galactosidase staining, were used to investigate the mechanism of 
action of flubendazole on the cells. Flubendazol induced accumulation of cells in G2/M phases 
of the cell cycle and significantly inhibited cell proliferation in concentration-dependent and 
time-dependent manner in comparison to the control samples. 
In conclusion, anthelmintic benzimidazole drug flubendazole shows significant cytostatic effect 
in human intestinal cancer cell lines.  
